Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA1c in type 2 diabetes
- PMID: 30986829
- DOI: 10.7326/ACPJ201904160-039
Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA1c in type 2 diabetes
Comment on
-
Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus.Cochrane Database Syst Rev. 2018 Dec 17;12(12):CD013228. doi: 10.1002/14651858.CD013228. Cochrane Database Syst Rev. 2018. PMID: 30556900 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical